Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|May 27, 2022
QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?Amy Tanti, Benjamin Micallef, Janis Vella Szijj, et al.
The International Journal of Risk & Safety in Medicine|May 31, 2024
An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in MaltaElisa Curtolo, Benjamin Micallef, Janis Vella Szijj, et al.
Scientia Pharmaceutica|July 15, 2015
Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory PerspectiveJohn Joseph Borg, Paolo Tomasi, Luca Pani, et al.
Drug Metabolism and Personalized Therapy|May 31, 2019
Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in pointLuana Mifsud Buhagiar, Benjamin Micallef, John Joseph Borg, et al.
Therapeutic Advances in Rare Disease|December 20, 2023
The pharmacological treatment of granulomatosis with polyangiitis: a review of clinical trials registered in clinicaltrials.gov and the International Clinical Trials Registry PlatformJanet Sultana, Nikita Camilleri, Salvatore Crisafulli, et al.
Expert Opinion on Drug Safety|April 12, 2021
Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EUDianne Butler, Katarina Vucic, Sabine Straus, et al.
Regulatory Toxicology and Pharmacology : RTP|June 28, 2025
The value of a structured, systematic approach to benefit-risk assessment of medicines: A South African regulator case studyLorraine Danks, Boitumelo Semete-Makokotlela, Donald Chuma, et al.
Therapeutic Advances in Drug Safety|August 25, 2015
European Union pharmacovigilance capabilities: potential for the new legislationJohn Joseph Borg, Amy Tanti, Dimitrios Kouvelas, et al.
AAPS Pharmscitech|October 14, 2017
Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human UseMark Cilia, Sol Ruiz, Peter Richardson, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|March 25, 2024
Nivolumab Safety in Renal Cell Carcinoma: A Case ReportJames Debono, Dustin Balzan, John Joseph Borg, et al.
Pageof 3